Aufklappen
Schliessen
DAVITA HEALTHCARE PARTNERS INC | 49,59 Euro | +0,495 +1,01 % | |
| WKN: 897914 ISIN: US23918K1088 Ticker-Symbol: TRL | Stuttgart | 17.04.14 | 08:01 Uhr |
Branche GesundheitswesenAktienmarkt S&P 500 |
|
|
Aktuelle News zu DAVITA Aktie
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
| Leser | Medien | |
|---|---|---|---|---|
| DAVITA Aktie jetzt ab 5 Dollar handeln! | LYNX | |||
--> Artikel lesen | ||||
| Mi | Highmark partnering with DaVita in dialysis care | 1 | bizjournals | |
--> Artikel lesen | ||||
| Mi | Uptrend Call Working As DaVita Stock Rises 9.6% | 2 | SmarTrend | |
--> Artikel lesen | ||||
| Mi | DaVita's Teammate-Focused Culture Gains National and Local Awards | 5 | PR Newswire | |
| DENVER, April 16, 2014 /PRNewswire-USNewswire/ -- DaVita, a division of DaVita HealthCare Partners Inc. (NYSE: DVA) and a leading provider of kidney care services, today announced it received three... --> Artikel lesen | ||||
| Mi | DaVita HealthCare Partners Inc. Schedules 1st Quarter 2014 Investor Conference Call | 6 | PR Newswire | |
| DENVER, April 15, 2014 /PRNewswire/ --DaVita HealthCare Partners Inc. (NYSE: DVA) announced today that it will hold its quarterly conference call to discuss first quarter results on Thursday, May... --> Artikel lesen | ||||
| Mo | DaVita Clinical Research Presents Research Results at the American Nephrology Nurses Association National Symposium | 5 | PR Newswire | |
| ANAHEIM, Calif., April 14, 2014 /PRNewswire-USNewswire/ -- DaVita Clinical Research (DCR) (NYSE: DVA), a specialty contract research organization with services spanning the full spectrum of drug and... --> Artikel lesen | ||||
| 11.04. | Risk-Reward Balanced at DaVita | 4 | Zacks | |
--> Artikel lesen | ||||
| 11.04. | Healthcare Companies Enter into Acquisitions and Partnerships, Receive FDA Approvals, Make Appointments, and Receive Recognitions - Analyst Notes on Nordion, Abbott, Covidien, DaVita, and Sirona | 10 | PR Newswire | |
| NEW YORK, April 11, 2014 /PRNewswire/ --
Today, Analysts Review released its analysts' notes regarding Nordion Inc. (NYSE: NDZ), Abbott Laboratories (NYSE: ABT), Covidien plc (NYSE: COV), DaVita... --> Artikel lesen | ||||
| 09.04. | DaVita Bullish Moving Average Crossover Alert | - | SmarTrend | |
--> Artikel lesen | ||||
| 08.04. | DaVita signs CBRE to handle facilities managment for clinics | 1 | bizjournals | |
--> Artikel lesen | ||||
| 08.04. | Independence Blue Cross and DaVita HealthCare Partners Announce Joint Venture | 2 | PR Newswire | |
| PHILADELPHIA, April 8, 2014 /PRNewswire/ --Independence Blue Cross (Independence) and DaVita HealthCare Partners today announced the creation of Tandigm Health. This unique joint venture, based in... --> Artikel lesen | ||||
| 05.04. | Can DaVita HealthCare Partners Inc's Run Last? | 4 | Motley Fool | |
--> Artikel lesen | ||||
| 04.04. | DaVita Up 12.1% Since SmarTrend Uptrend Call | - | SmarTrend | |
--> Artikel lesen | ||||
| 04.04. | Study Results, Stock Price Movements, Product Launches, and Updates on Court Case Trials - Analyst Notes on Medtronic, Alexion, DaVita, Thermo Fisher Scientific, and Medicines | 20 | PR Newswire | |
| NEW YORK, April 4, 2014 /PRNewswire/ --
Today, Analysts Review released its analysts' notes regarding Medtronic, Inc. (NYSE: MDT), Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN), DaVita, Inc. (NYSE:... --> Artikel lesen | ||||
| 28.03. | Health Care Equities Technical Momentum -- Research on Laboratory Corp. of America, Omnicare, DaVita HealthCare Partners, and MEDNAX | 7 | PR Newswire | |
| LONDON, March 28, 2014 /PRNewswire/ --
On Wednesday, March 26, 2014, the NASDAQ Composite finished at 4,173.58, down 1.43%, the Dow Jones Industrial Average fell by 0.60% to close the session at... --> Artikel lesen | ||||
| 25.03. | DaVita Crosses Above its 10-day MA | - | SmarTrend | |
--> Artikel lesen | ||||
| 21.03. | DaVita: Short-Term Headwinds Could Create Buying Opportunity For Long-Term Investors | 6 | Seeking Alpha | |
--> Artikel lesen | ||||
| 21.03. | DaVita Soars to New 52-Week High - Analyst Blog | 1 | Benzinga.com | |
--> Artikel lesen | ||||
| 21.03. | Watch for Continued Gains in Shares of DaVita | 1 | SmarTrend | |
--> Artikel lesen | ||||
| 21.03. | DaVita Soars to New 52-Week High | 1 | Zacks | |
--> Artikel lesen | ||||
| 20.03. | DAVITA HEALTHCARE PARTNERS INC. - 8-K, Current Report | - | SEC Filings | |
--> Artikel lesen | ||||
Seite:
1 2 3 4 5 Weiter >>
152 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten:
VerkaufenHaltenKaufen
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | |
|---|---|---|---|---|
| FRESENIUS | 107,10 | -0,05 % | dpa-AFX Überblick: ANALYSTEN-EINSTUFUNGEN vom 17.04.2014: ADIDAS, ALLIANZ, ASTRAZENECA, BANCO SANTANDER, BASF, BAYER, BAYWA, BB BIOTECH, BHP BILLITON, BMW, COMDIRECT BANK, CONTINENTAL, CREDIT SUISSE, ... | |
| Ausgewählte Analysten-Einstufungen im
dpa-AFX-Nachrichtendienst vom 17.04.2014
ADIDAS
FRANKFURT - Die Deutsche Bank hat das Kursziel für Adidas
vor Zahlen von 83 auf 80 (Kurs 74,92) Euro gesenkt... --> Artikel lesen | ||||
| ECKERT & ZIEGLER | 24,12 | +0,29 % | DGAP-HV: Eckert & Ziegler Strahlen- und -2- | |
| DJ DGAP-HV: Eckert & Ziegler Strahlen- und Medizintechnik AG: Bekanntmachung der Einberufung zur Hauptversammlung am 22.05.2014 in Berlin mit dem Ziel der europaweiten Verbreitung gemäß §121 AktG
... --> Artikel lesen | ||||
| FRESENIUS MEDICAL CARE | 49,08 | -0,04 % | FMC und Joslin Diabetes entwickeln gemeinsam Behandlungskonzepte | |
| Der Dialysespezialist Fresenius Medical Care (FMC) und die gemeinnützige US-Organisation Joslin Diabetes Center arbeiten künftig zusammen. Konkret geht es um die Entwicklung gemeinsamer Behandlungskonzepte... --> Artikel lesen | ||||
| MEDTRONIC | 42,77 | +1,26 % | Acquisitions, Director Appointments, Collaborations, New Product Launches, and Earnings Guidance Revisions - Analyst Notes on Questcor, Regeneron, Lilly, Medtronic and Alexion | |
| NEW YORK, April 14, 2014 /PRNewswire/ --
Today, Analysts Review released its analysts' notes regarding Questcor Pharmaceuticals Inc. (NASDAQ: QCOR), Regeneron Pharmaceuticals Inc. (NASDAQ: REGN)... --> Artikel lesen | ||||
| CARL ZEISS MEDITEC | 20,88 | +0,75 % | dpa-AFX Überblick: ANALYSTEN-EINSTUFUNGEN vom 31.03.2014 bis 04.04.2014: AAREAL BANK, AIRBUS, AIXTRON, AXA, BANCO SANTANDER, BASF, BAUER, BECHTLE, BP, CARL ZEISS MEDITEC, DAIMLER, DEUTSCHE POST, DIALOG ... | |
| Ausgewählte Analysten-Einstufungen im
dpa-AFX-Nachrichtendienst in der Woche vom 31.03.2014 bis 04.04.2014
MONTAG
ELRINGKLINGER AG
FRANKFURT - Die Commerzbank hat ElringKlinger nach
unterdurchschnittlicher... --> Artikel lesen | ||||
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und mit der Push-Technologie von